Volume 30, Issue 2 (8-2017)                   jdm 2017, 30(2): 89-96 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jafari A, Gholizadeh N, Ramezani R, Razavi H E, Najafi S. Evaluation of survival rate in patients with laryngeal cancer. jdm 2017; 30 (2) :89-96
URL: http://jdm.tums.ac.ir/article-1-5638-en.html
1- Associate Professor, Department of Pediatric, School of Dentistry, Alborz University of Medical Sciences, Karaj, Iran
2- Associate Professor, Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
3- Head of Center for Disease Control and Prevention Non-Communicable Diseases Unit Ministry of Health, Cancer Office, Tehran, Iran
4- Post-Graduate Student, Department of Operative Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
5- Associate Professor, Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran; Member of Dental Research Center, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (9750 Views)

Background and Aims: Cancer is the second most common cause of death in developed countries. The goal of this study was to determine the important epidemiologic factors affecting diagnosis and survival rate of patients with laryngeal SCC, for prevention, control and increase longevity.
Materials and Methods: In this study, all the cases recorded at the Center of Cancer Office of the Iran Ministry of Health in Tehran between 2005-2009 were examined. From 513 cases, 279 that their follow-up was possible by phone or postal address were included in the study. Data collection were performed from questionnaire. The data were analyzed by SPSS version 20. The Kaplan Meier survival curves were utilized and, moreover, the corresponding influential factors were examined by using the Cox regression test.
Results: The mean age of patients were 61.1 years (SD=10.54). The gender of 92.1% of patients were male. The most widely used method for the treatment was a combination of three methods of surgery, radiation therapy, and chemotherapy. The overall five-year survival rate was 75.7% (SD=0.03). The gender, histological differentiation, and professional delay did not exhibit a statistical correlation with the survival rate (P=0.38, 0.14, 0.52), whereas the age and patient delay had a statistically significant relation with the survival rate (P=0.03, 0.07).
Conclusion: The survival rate was lower in older patients. Patient and professional delays were high, which need more attention for improving the quality of life.
 
Full-Text [PDF 557 kb]   (3421 Downloads)    
Type of Study: Research | Subject: general
Received: 2017/08/13 | Accepted: 2017/08/13 | Published: 2017/08/13

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by: Yektaweb